Skip to content

Mounjaro KwikPen update April 2026 (UK): modified pen expected from April 2026

Eli Lilly has sent a Mounjaro KwikPen update to UK clinicians for April 2026. Additionally, this update outlines how Eli Lilly plans to manage the transition as the current pen stock runs down. This Mounjaro KwikPen update April 2026 relates to the KwikPen device, not a change to tirzepatide itself. Eli Lilly says the modified Mounjaro KwikPen reduces leftover medicine. In other words and end to the “Fifth Dose

During the Mounjaro KwikPen update April 2026 rollout in the UK, pharmacies and prescribers may supply either the initial Mounjaro KwikPen or the modified Mounjaro KwikPen for a period of time. This will occur while stock transitions. That means you could receive either pen version even if your Mounjaro strength stays the same.

Estimated reading time: 7 minutes

Mounjaro KwikPen update April 2026 UK modified pen reduces leftover medicine and shows final dose delivered

MounjaroUK Mod, Due-Freedom-5968, has also put together a useful community FAQ that summarises what people are seeing with the revised Mounjaro KwikPen and where it has appeared so far. We’re sharing this as patient-led context (not an official Eli Lilly document), and we recommend treating the figures as informal until you can verify them from packaging or an official leaflet. Image credit: the FAQ graphic compiled by Due-Freedom-5968 on Reddit.

A snippet of Due-Freedom-5968’s FAQ summary: Eli Lilly lists an advertised capacity of 2.4 mL. However, the current pen holds about 3.2 mL and the revised pen holds about 2.6 mL. Additionally, these reports say the change is due in April 2026 and that the revised pen has reportedly launched in Germany, Austria, the Czech Republic, Sweden, and the USA.

Original Image Credit: freakotto – Edited Image image: Credit to Due-Freedom-5968

Mounjaro KwikPen update April 2026: what Lilly told UK clinicians (quoted verbatim)

The Mounjaro®▼(tirzepatide) KwikPen® device has been modified to reduce leftover medicine and make it easier to track that the final dose has been administered. This indicates that the pen is ready to be discarded. The modified KwikPen works the same way as the initial device.

The initial and modified Mounjaro KwikPens are both disposable multi-dose single-patient-use pre-filled pens. They contain the volume of solution necessary for priming before each injection and the delivery of 4 fixed 0.6mL doses (one dose administered weekly).

We anticipate that the modified KwikPen will become available in the UK from April 2026. Once existing stock of the initial KwikPen is depleted, supply will transition to the modified KwikPen. Therefore, healthcare providers and patients can expect both versions to be available in the market for a period of time for all dose strengths during this transition.

The GTIN and PIP codes remain unchanged.

The modified KwikPen works in the same way as the initial device, but there are a few visual and structural updates.

Plunger Position: The plunger sits further down in the cartridge when the pen is unused.

An added internal component extends the plunger’s length. Additionally, the Instructions for Use (IFU) shows this change in the Mounjaro KwikPen Guide to Parts section.

After the fourth dose, the plunger moves near the end of the pen and clearly indicates the pen is finished and ready to be discarded. Consequently, you should not expect meaningful medicine to remain after dose four.

Mounjaro KwikPen update April 2026 UK: what changes you may notice

Eli Lilly describes visual and structural changes to the modified Mounjaro KwikPen:

Mounjaro KwikPen plunger position (modified pen)

Eli Lilly says the plunger sits further down in the cartridge when the pen is unused.

Mounjaro KwikPen extended plunger (modified pen)

Eli Lilly says a new internal component sits behind the plunger, extending its length. Eli Lilly says the IFU “Guide to Parts” section shows this change. Consequently, patients can reference that diagram to identify the updated internal plunger component.

Mounjaro KwikPen leftover medicine indicator after dose 4 (modified pen)

Eli Lilly says after dose 4 the plunger will be near the end of the pen, clearly indicating the pen is ready to be discarded.

Mounjaro KwikPen update April 2026: what stays the same (per Eli Lilly)

Eli Lilly says the modified Mounjaro KwikPen works the same way as the initial pen.

They state both versions are disposable, multi-dose, single-patient-use, pre-filled pens that deliver four fixed 0.6 mL doses, with one dose taken weekly. Consequently, each pen covers four weekly doses at the prescribed strength, so it supports a four-week course when you use one dose per week.

Eli Lilly says the Mounjaro KwikPen GTIN and PIP codes remain unchanged.

Mounjaro KwikPen update April 2026 UK rollout: timing and transition

Eli Lilly anticipates the modified Mounjaro KwikPen will become available in the UK from April 2026. Eli Lilly says it will transition supply after it depletes existing stock of the original pen. Consequently, you may continue to receive the initial pen until pharmacies run through remaining inventory. Moreover, both versions may be available for a period of time across all strengths during the changeover.

Practical implication for Mounjaro patients in the UK: your pharmacy may dispense either pen version depending on stock. This applies even if your strength and weekly schedule stay the same.

Mounjaro KwikPen update April 2026: what this means for UK patients (and why we word this carefully)

Some patients have noticed that the current Mounjaro KwikPen can appear to leave a visible amount of liquid after the fourth dose. Online, people often refer to “leftover liquid” and some describe trying to use that remainder as an extra, unofficial dose.

For our own legal skin, we have to be careful how we describe this. We can’t tell anyone to do that, and we won’t frame it as advice.

What we can say, factually, is this: Eli Lilly’s Mounjaro KwikPen update April 2026 explicitly says the modified pen reduces leftover medicine. It also makes the end-of-pen state clearer after dose 4. If you previously saw more medicine left in the pen, or you relied on that leftover liquid in any way, expect less to remain and expect a clearer signal when the pen finishes.

Mounjaro KwikPen update April 2026 UK: frequently asked questions

Will the medicine change with the Mounjaro KwikPen update April 2026?

No. Eli Lilly’s update describes a Mounjaro KwikPen device modification, not a change to tirzepatide.

Will my dosing schedule change with the Mounjaro KwikPen update April 2026?

No. Eli Lilly states each pen delivers four fixed 0.6 mL doses, with one dose administered weekly.

Do I need to learn a new injection method for the modified Mounjaro KwikPen?

No. Eli Lilly says the modified pen works the same way as the initial device. Follow the Instructions For Use provided with your pen.

Will UK pharmacies stock both pens during the Mounjaro KwikPen update April 2026 rollout?

Yes, for a period. Eli Lilly says both versions may be available during the transition.

Do GTIN and PIP codes change in the Mounjaro KwikPen update April 2026?

No. Eli Lilly says GTIN and PIP codes remain unchanged.

About this Mounjaro KwikPen update April 2026

Monj publishes UK-facing updates on Mounjaro devices, supply, and prescribing changes to help patients understand what may change at pharmacy level. This page includes the clinician newsletter text provided, quoted word-for-word. If you receive pharmacy notices, packaging photos, or official dispensing messages that confirm the UK changeover timing in real-world supply, send them to us. We’ll add them with dates and evidence.